Loading insider details...
Beta
Latest Form 4 (Mar 23, 2026): Grant/Award of 60,389 EXAS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 23, 2026 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 60,389 | n/a |
| Mar 4, 2026 | EXACT SCIENCES CORP (EXAS) | Exercise/Conversion | 3,900 | $19.6K |
| Feb 27, 2026 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 23,224 | n/a |
| Dec 30, 2025 | EXACT SCIENCES CORP (EXAS) | Exercise/Conversion | 3,955 | n/a |
| Mar 4, 2025 | EXACT SCIENCES CORP (EXAS) | Exercise/Conversion | 3,780 | n/a |
| Feb 27, 2025 | EXACT SCIENCES CORP (EXAS) | Exercise/Conversion | 3,954 | n/a |
| Feb 21, 2025 | EXACT SCIENCES CORP (EXAS) | Exercise/Conversion | 2,248 | n/a |
| May 2, 2024 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 218 | n/a |
| Apr 3, 2024 | EXACT SCIENCES CORP (EXAS) | Sale | 2,000 | $140.0K |
| Apr 1, 2024 | EXACT SCIENCES CORP (EXAS) | Sale | 2,000 | $140.0K |